Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03770000
Title Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California, Hellen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
University of Miami-Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Rush University Cancer Center Chicago Illinois 60612 United States Details
The University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Norton Cancer Institute, St Matthews Campus Louisville Kentucky 40207 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
John Theurer Cancer Center, Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232-5505 United States Details
The University of Texas MD Anderson Cancer Center, Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field